Evidence map›Paper›PMID 29229991›Full record

ArticleCell death and differentiation2018

BOK promotes chemical-induced hepatocarcinogenesis in mice.

Tatiana Rabachini, Yuniel Fernandez-Marrero, Matteo Montani, Giulio Loforese, Valentina Sladky, Zhaoyue He, Daniel Bachmann, Simone Wicki, Andreas Villunger, Deborah Stroka and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.Journal of experimental & clinical cancer research : CR · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Bok: real killer or bystander with non-apoptotic roles?Frontiers in cell and developmental biology · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Tatiana RabachiniInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland.
Yuniel Fernandez-MarreroInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland.
Matteo MontaniInstitute of Pathology, University of Bern, Murtenstrasse 31, CH-3008, Bern, Switzerland.
Giulio LoforeseDepartment of Clinical Research, Visceral and Transplantation Surgery, University of Bern, Murtenstrasse 35, CH-3008, Bern, Switzerland.ORCID http://orcid.org/0000-0001-8418-8394
Valentina SladkyDivision of Developmental Immunology, BIOCENTER, Medical University of Innsbruck, Innrain 80/II, 6020, Innsbruck, Austria.
Zhaoyue HeInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland.
Daniel BachmannInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland.
Simone WickiInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland.
Andreas VillungerDivision of Developmental Immunology, BIOCENTER, Medical University of Innsbruck, Innrain 80/II, 6020, Innsbruck, Austria.
Deborah StrokaDepartment of Clinical Research, Visceral and Transplantation Surgery, University of Bern, Murtenstrasse 35, CH-3008, Bern, Switzerland.
Thomas KaufmannInstitute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010, Bern, Switzerland. thomas.kaufmann@pki.unibe.ch.ORCID http://orcid.org/0000-0001-9906-874X
University of Bern · CHInnsbruck Medical University · AT

Funding

Austrian Science Fund FWF I 1298
6 · The paper itself

Abstract

BCL-2-related ovarian killer (BOK) is a conserved and widely expressed BCL-2 family member with sequence homology to pro-apoptotic BAX and BAK, but with poorly understood pathophysiological function. Since several members of the BCL-2 family are critically involved in the regulation of hepatocellular apoptosis and carcinogenesis we aimed to establish whether loss of BOK affects diethylnitrosamine (DEN)-induced hepatocarcinogenesis in mice. Short-term exposure to DEN lead to upregulation of BOK mRNA and protein in the liver. Of note, induction of CHOP and the pro-apoptotic BH3-only proteins PUMA and BIM by DEN was strongly reduced in the absence of BOK. Accordingly, Bok

Indexed as

AnimalsApoptosisCarcinoma, HepatocellularCell CycleCell Transformation, NeoplasticDiethylaminesLiver NeoplasmsMiceMice, KnockoutProto-Oncogene Proteins c-bcl-2Bok protein, mouseDiethylaminesN-nitrodiethylamineProto-Oncogene Proteins c-bcl-2

Identifiers

PMID29229991
PMCPMC5864194
OpenAlexW2773645632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.